A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
13 02 2021
Historique:
received: 30 06 2020
accepted: 02 09 2020
pubmed: 6 9 2020
medline: 3 3 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

Care homes have experienced a high number of coronavirus disease 2019 (COVID-19)-related deaths among residents since the onset of the pandemic. However, up to May 2020, there has been a lack of information about the extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among residents and staff in care homes and limited testing in this setting. Combined nose and throat swab testing for SARS-CoV-2 RNA was carried out in 2455 residents and staff across 37 care homes in the London Borough of Bromley across a 3-week period. Results were reported within 24 hours of sample delivery, and data were collected on the presence or absence of symptoms. Overall, the point prevalence of SARS-CoV-2 infection was 6.5%, with a higher rate in residents (9.0%) than in staff (4.7%). A key finding was the high proportion of asymptomatic infection detected in staff (69%) and residents (51%), with evidence of underdetection of symptoms by care home staff. The high proportion of asymptomatic infection combined with underdetection of symptoms by care home staff indicates that offering a test to all residents and staff in care homes with rapid reporting of results would assist accurate identification of infected individuals, facilitating prompt infection prevention and control action.

Sections du résumé

BACKGROUND
Care homes have experienced a high number of coronavirus disease 2019 (COVID-19)-related deaths among residents since the onset of the pandemic. However, up to May 2020, there has been a lack of information about the extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among residents and staff in care homes and limited testing in this setting.
METHODS
Combined nose and throat swab testing for SARS-CoV-2 RNA was carried out in 2455 residents and staff across 37 care homes in the London Borough of Bromley across a 3-week period. Results were reported within 24 hours of sample delivery, and data were collected on the presence or absence of symptoms.
RESULTS
Overall, the point prevalence of SARS-CoV-2 infection was 6.5%, with a higher rate in residents (9.0%) than in staff (4.7%). A key finding was the high proportion of asymptomatic infection detected in staff (69%) and residents (51%), with evidence of underdetection of symptoms by care home staff.
CONCLUSIONS
The high proportion of asymptomatic infection combined with underdetection of symptoms by care home staff indicates that offering a test to all residents and staff in care homes with rapid reporting of results would assist accurate identification of infected individuals, facilitating prompt infection prevention and control action.

Identifiants

pubmed: 32889532
pii: 5901911
doi: 10.1093/infdis/jiaa565
pmc: PMC7499645
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-388

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Agnes Marossy (A)

One Bromley, Global House, Hayes, Kent, United Kingdom.

Stefan Rakowicz (S)

Bromleag Care Practice, Kelsey Park Farmhouse, Beckenham Beacon Hospital, Beckenham, Kent, United Kingdom.

Angela Bhan (A)

NHS South East London Clinical Commissioning Group, London, United Kingdom.

Sarah Noon (S)

Bromleag Care Practice, Kelsey Park Farmhouse, Beckenham Beacon Hospital, Beckenham, Kent, United Kingdom.

Amanda Rees (A)

NHS South East London Clinical Commissioning Group, London, United Kingdom.

Manjinder Virk (M)

South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Ayazali Nazafi (A)

South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Evie Hay (E)

South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Louise de Thomasson (L)

South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Christina Windle (C)

NHS South East London Clinical Commissioning Group, London, United Kingdom.

Mark Zuckerman (M)

South London Specialist Virology Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH